First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

This grant opportunity (PAR-25-180) from NIH supports first-in-human and early-stage clinical trials of novel investigational drugs or neuromodulatory device-based interventions for psychiatric disorders. A U01 clinical trial is required, and the CFDA number is 93.242.